Matthew B Laurens
Overview
Explore the profile of Matthew B Laurens including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
89
Citations
2268
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Nampota-Nkomba N, Nyirenda O, Datta S, Mapemba V, Patel P, Misiri T, et al.
EClinicalMedicine
. 2025 Mar;
81:103100.
PMID: 40034570
Background: We assessed persistence of typhoid immunity conferred by Vi polysaccharide-tetanus toxoid (Vi-TT) conjugate vaccine (TCV) four years post-vaccination and immunogenicity of a booster dose of Vi-TT given at age...
2.
Laurens M
J Infect Dis
. 2025 Jan;
PMID: 39879637
Clinical trials that employ human challenge, also known as controlled human infection models (CHIM), have rapidly advanced vaccine development for multiple pathogens, including at least 30 disease models to date....
3.
Nampota-Nkomba N, Nyirenda O, Mapemba V, Masonga R, Patel P, Misiri T, et al.
Hum Vaccin Immunother
. 2024 Sep;
20(1):2384760.
PMID: 39263923
Vaccine safety and immunogenicity data in human immunodeficiency virus (HIV)-exposed uninfected (HEU) children are important for decision-making in HIV and typhoid co-endemic countries. In an open-label study, we recruited Malawian...
4.
Bailey R, Lawton J, Niangaly A, Stucke E, Bailey J, Berry A, et al.
J Infect
. 2024 Aug;
89(4):106257.
PMID: 39216830
Children with hemoglobin AC or AS have decreased susceptibility to clinical malaria. Parasite variant surface antigen (VSA) presentation on the surface of infected erythrocytes is altered in erythrocytes with hemoglobin...
5.
Neuzil K, Patel P, Ndeketa L, Laurens M, Gordon M
Lancet
. 2024 Aug;
404(10454):748.
PMID: 39181588
No abstract available.
6.
Tebben K, Yirampo S, Coulibaly D, Kone A, Laurens M, Stucke E, et al.
Microbiol Spectr
. 2024 Aug;
12(10):e0096024.
PMID: 39162546
Importance: Our work seeks to understand how the immune response to malaria changes between infections that occur during low and high malaria transmission seasons, and highlights that immune gene expression...
7.
Laurenson A, Laurens M
PLoS Pathog
. 2024 Jun;
20(6):e1012309.
PMID: 38935630
No abstract available.
8.
Gene expression analyses reveal differences in children's response to malaria according to their age
Tebben K, Yirampo S, Coulibaly D, Kone A, Laurens M, Stucke E, et al.
Nat Commun
. 2024 Mar;
15(1):2021.
PMID: 38448421
In Bandiagara, Mali, children experience on average two clinical malaria episodes per year. However, even in the same transmission area, the number of uncomplicated symptomatic infections, and their parasitemia, can...
9.
Friedman-Klabanoff D, Berry A, Travassos M, Shriver M, Cox C, Butts J, et al.
J Infect Dis
. 2024 Feb;
229(6):1883-1893.
PMID: 38330357
Background: Malaria is preventable yet causes >600 000 deaths annually. RTS,S, the first marketed malaria vaccine, has modest efficacy, but improvements are needed for eradication. Methods: We conducted an open-label,...
10.
Patel P, Liang Y, Meiring J, Chasweka N, Patel P, Misiri T, et al.
Lancet
. 2024 Jan;
403(10425):459-468.
PMID: 38281499
Background: Randomised controlled trials of typhoid conjugate vaccines among children in Africa and Asia have shown high short-term efficacy. Data on the durability of protection beyond 2 years are sparse....